The combination of ALBI and AFP response: A small step forward in HCC

Liver Int. 2023 Feb;43(2):271-273. doi: 10.1111/liv.15494.

Authors

Landon L Chan¹, Stephen L Chan^{2

3}

Affiliations

¹ Department of Oncology, Princess Margaret Hospital, Hong Kong, China.
² Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China.
³ State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, China.

PMID: 36680318
DOI: 10.1111/liv.15494

No abstract available

Publication types

Editorial
Comment

MeSH terms

Bilirubin
Carcinoma, Hepatocellular*
Humans
Liver Neoplasms*
Prognosis
Retrospective Studies
Serum Albumin
alpha-Fetoproteins

Substances

alpha-Fetoproteins
Bilirubin
Serum Albumin